engage:BDR deploys ad exchange for North American cannabis brands

Published 15-APR-2019 10:11 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

engage:BDR (ASX:EN1) has expanded its solutions into the cannabis and CBD advertising space.

Until now, there has been few opportunities for cannabis advertisers to acquire digital ad inventory, due to constraints around cannabis advertising.

EN1 has launched a customer curated inventory package suite, specifically designed to provide cannabis brands and advertisers with a medium to access display, video and native inventory.

Beginning last week, the company’s programmatic exchange offered private marketplace opportunities with top 1000 US websites and apps, via personalised ad solutions for niche cannabis clients. This development is important for EN1, as it builds off its 2019 strategic plan announcement on 11 February.

Under the plan, engage:BDR, with its IconicReach and AdCel products, plan to pursue several new projects, including digital solutions for domestic cannabis brands, as part of its continued incremental revenue growth.

Private marketplace for cannabis

To address increasing demand, EN1 has now enabled cannabis advertisers to access its programmatic exchange, in addition to its current offering for said advertisers through IconicReach. AdCel is now exploring the possibility of expanding cannabis and CBD advertising to include mobile ads through a self-serve marketplace.

EN1’s IconicReach will also provide cannabis brands access to prominent influencers who are subject matter experts, to help create and distribute content across their social media channels.

Thanks to EN1’s new programmatic distribution channel, brands can now syndicate their high-quality influencer content across programmatic media channels, providing the company with a unique differentiator amongst their competitors and tremendous value to advertisers using the platform.

As previously mentioned, EN1 now offers cannabis advertisers the opportunity to connect with premium comScore top 1000 sites/publishers to reach their audiences. These include household names such as Garnett (who represent USA Today), as well as Generation Premium and Bandsintown.

With these networks on board, EN1 enables cannabis brands to efficiently and effectively expand their reach and target audience size. Select publishers have opted in to accept cannabis and or CBD advertising; all other publishers remain unaffected.

Advertising process

EN1 has worked closely with its publishers to establish creative guidelines for cannabis advertisers, eliminating the guesswork related to creative compliance. The existence of these guidelines makes it easy for EN1’s new cannabis partners to start on its platforms.

EN1’s managed services team handles all of the heaving lifting, performance optimisation and negotiations with suppliers, reducing the need for the advertiser to have their own internal resources dedicated to maneuvering within the advertising ecosystem.

Benefits and 2019 strategic coals

As mentioned previously, the launch of this marketplace is a major coup for EN1. All of the company’s 2019 goals focus on one outcome – profitability.

Engaging the cannabis industry enables the use of the company’s core tech stack and takes advantage of EN1’s relationships with key players in the field. This new customer channel is targeting 55-60% margins.

As of today, less than a handful of legitimate programmatic advertising options exist in the U.S. for cannabis advertisers. This fresh marketplace launch enables EN1 to shore up its position as a market leader in the area.

tags

ADTECH TECH


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X